Skip to main content Accessibility help
×
Hostname: page-component-76fb5796d-2lccl Total loading time: 0 Render date: 2024-04-30T06:43:27.474Z Has data issue: false hasContentIssue false

9 - Alpha-1 Antitrypsin Deficiency and the Liver

Published online by Cambridge University Press:  08 August 2009

Zobair M. Younossi
Affiliation:
Inova Fairfax Hospital, Annandale, VA
Get access

Summary

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Laurell, C-B, Eriksson, A. The electrophoretic alpha 1-globulin pattern of serum in alpha-1 antitrypsin deficiency. Scand J Clin Lab Invest 1963;15:132.CrossRefGoogle Scholar
Sharp, HL, Bridges, RA, Krivit, W, Freier, ER. Cirrhosis associated with alpha-1 antitrypsin deficiency: a previously unrecognized inherited disorder. J Lab Clin Med 1969;73:934–9.Google ScholarPubMed
,American Thoracic Society/European Respiratory Society:Standards for the Diagnosis and Management of Individuals with Alpha-1 Antitrypsin Deficiency Lung Disease. Am J Respir Crit Care Med 2003;168:823–49.Google Scholar
Stoller, JK, Aboussouan, LS. Alpha-1 antitrypsin deficiency. Lancet 2005;365:2225–36.CrossRefGoogle Scholar
Carrell, R, Lomas, D. Alpha-1 antitrypsin deficiency- a model for conformational diseases. N Engl J Med 2002;346:45–53.CrossRefGoogle ScholarPubMed
Turino, GM, Barker, AF, Brantly, ML, et al. Clinical features of individuals with PI*SZ phenotype of alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med 1996;154:1718–25.CrossRefGoogle ScholarPubMed
,Perlmutter DH. Alpha-1 antitrypsin deficiency: diagnosis and treatment. Clin Liver Dis 2004;8:839–59.CrossRefGoogle Scholar
Sapienza, MS, Porayko, M. Alpha-1 antitrypsin deficiency and liver disease. Clinical Perspectives in Gastroenterology 2002;5:40–8.Google Scholar
Primhak, RA, Tanner, MS. Alpha-1 antitrypsin deficiency. Arch Dis Child. 2001;85:2–5.CrossRefGoogle ScholarPubMed
Sveger, T. Liver disease in alpha-1 antitrypsin deficiency detected by screening of 200,000 infants. N Engl J Med 1976;294: 1316–21.CrossRefGoogle ScholarPubMed
Lang, T, Muhlbauer, M, Strobelt, M, Weidinger, S, Hadorn, HB. Alpha-1-antitrypsin deficiency in children: liver disease is not reflected by low serum levels of alpha-1 antitrypsin: a study on 48 pediatric patients. Eur J Med Res 2005;10:509–14.Google Scholar
Eriksson, S. Alpha-1 antitrypsin deficiency and liver cirrhosis in adults: an analysis of 35 Swedish autopsied cases. Acta Med Scand 1987;221:461–7.CrossRefGoogle ScholarPubMed
Campos, MA, Wanner, A, Zhang, G, Sandhaus, RA. Trends in the diagnosis of symptomatic patients with alpha-1 antitrypsin deficiency between 1968 and 2003. Chest 2005;128:1179–86.CrossRefGoogle Scholar
Stoller, JK, Sandhaus, RA, Turino, G, Dickson, R, Rodgers, K, Strange, C. Delay in diagnosis of alpha-1 antitrypsin deficiency: a continuing problem. Chest 2005;128:1989– 94.CrossRefGoogle ScholarPubMed
Lieberman, J, Winter, B, Sastre, A. Alpha-1 antitrypsin PI-types in 965 COPD patients. Chest 1986;89: 370–3.CrossRefGoogle ScholarPubMed
,The Alpha-1 Antitrypsin Deficiency Registry Study Group. Prepared by: Schluchter MD, Barker AF, Crystal RG, et al. A registry of patients with severe deficiency of alpha-1 antitrypsin: design and methods. Chest 1994;106:1223–32.CrossRefGoogle Scholar
Silverman, EK, Pierce, JA, Province, MA, et al. Variability of pulmonary function in alpha-1 antitrypsin deficiency: clinical correlates. Ann Intern Med 1989;111:982–991.CrossRefGoogle ScholarPubMed
Needham, M, Stockley, RA. Alpha-1 antitrypsin deficiency 3: Clinical manifestations and natural history. Thorax 2004;59:441–5.CrossRefGoogle ScholarPubMed
Pauwels, RA, Buist, AS, Calverley, PMA, Jenkins, CR, Hurd, SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001;163:1256–76.CrossRefGoogle ScholarPubMed
Wewers, MD, Casolaro, MA, Sellers, SE, Swayze, S, McPhaul, KM, Wittes, JT, and Crystal, RG. Replacement therapy for alpha-1 antitrypsin deficiency associated with emphysema. N Engl J Med 1987;316:1055–62.CrossRefGoogle ScholarPubMed
Dirksen, A, Dijkman, JH, Madesen, F, Stoel, B, Hutchison, DCS, Ulrik, CS, Skovgaars, LT, Kok-Jensen, A, Rudolphus, A, Seersholm, N, Vrooman, HA, Reiber, JHC, Hansen, NC, Hecksher, T, Viskum, K, Stolk, J. A randomized clinical trial of alpha-1 antitrypsin augmentation therapy. Am J Respir Crit Care Med 1999;160:1468–72.CrossRefGoogle ScholarPubMed
,The Alpha-1 antitrypsin Deficiency Registry Study Group. Survival and FEV1 decline in individuals with severe deficiency of alpha-1 antitrypsin. Am J Respir Crit Care Med 1998;158:49–59.CrossRefGoogle Scholar
Seersholm, N, Wencker, M, Banik, N, et al. Does alpha-1 antitrypsin augmentation therapy slow the annual decline in FEV1 in patients with severe hereditary alpha-1 antitrypsin deficiency?Eur Respir J 1997;10:2260–63.CrossRefGoogle Scholar
Wencker, M, Fuhrmann, B, Banik, N, Konietzko, N. ,Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen. Longitudinal follow-up of patients with alpha (1)-protease inhibitor deficiency before and during therapy with IV alpha(1)-protease inhibitor. Chest 2001;119:737–44.CrossRefGoogle ScholarPubMed
Gildea, TR, Shermock, KM, Singer, ME, Stoller, JK. Cost-effectiveness analysis of augmentation therapy for severe alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med 2003;167:1387–92.CrossRefGoogle Scholar
Sandhaus, RA. Alpha-1 antitrypsin deficiency 6: New and emerging treatments for alpha1-antitrypsin deficiency. Thorax 2004;59:904–9.CrossRefGoogle ScholarPubMed
Lomas, DA. Mahadeva, R. Alpha-1 antitrypsin polymerization and the serpinopathies: pathobiology and prospects for therapy. J Clin Invest 2002;110:1585–90.CrossRefGoogle ScholarPubMed
Flotte, TR, Brantly, ML, Spencer, LT, et al. Phase I trial of intramuscular injection of a recombinant adeno-associated virus alpha-1 antitrypsin (rAAV2-CB-hAAT) gene vector to AAT-deficient adults. Hum Gene Ther 2004;15:93–128.Google ScholarPubMed
Kolb, M, Martin, G, Medina, M, Ask, K, Gauldie, J. Gene therapy for pulmonary diseases. Chest 2006;130:879–84.CrossRefGoogle ScholarPubMed
Burrows, JA, Willis, LK, Perlmutter, DH. Chemical chaperones mediate increased secretion of mutant alpha-1 antitrypsin (alpha-1 AT) Z: A potential pharmacological strategy for prevention of liver injury and emphysema in alpha-1 AT deficiency. Proc Natl Acad Sci USA 2000;97:1796–1801.CrossRefGoogle Scholar
Teckman, JH. Lack of effect of oral 4-phenylbutyrate on serum alpha-1-antitrypsin in patients with alpha-1 antitrypsin deficiency: A preliminary study. J Pediatr Gastroenterol Nutr 2004;39:34–7.CrossRefGoogle ScholarPubMed
Stoller, JK, Tomashefski, J, Crystal, RG, Arroliga, A, Strange, C, Killian, DN, Schluchter, MD, Wiedemann, HP. Mortality in individuals with severe deficiency of alpha-1 antitrypsin. Chest 2005;127:1196–1204.Google Scholar
Brantly, ML, Paul, LD, Miller, BH, et al. Clinical features and history of the destructive lung disease associated with alpha-1 antitrypsin deficiency of adults with pulmonary symptoms. Am Rev Respir Dis 1988;138:327.CrossRefGoogle ScholarPubMed
Janus, ED, Phillips, NT, Carrell, RW. Smoking, lung function and alpha-1 antitrypsin deficiency. Lancet 1985;1:152–4.CrossRefGoogle ScholarPubMed
Hutchison, DC, Tobin, MJ, Cooper, D. Longitudinal studies in alpha-1 antitrypsin deficiency: a survey by the British Thoracic Society. In: Taylor, JC, Mittman, C, eds. Pulmonary emphysema and proteolysis. Orlando: Academic Press, 1987.Google Scholar
Wu, MC, Eriksson, S. Lung function, smoking and survival in severe alpha-1 antitrypsin deficiency, PiZZ. J Clin Epidemiol 1988;41:1157–65.CrossRefGoogle ScholarPubMed
Seersholm, N, Kok-Jensen, A, Dirksen, A. Decline in FEV1 among patients with severe hereditary alpha-1 antitrypsin deficiency type PiZ. Am J Respir Crit Care Med 1995;152:1922–25.CrossRefGoogle ScholarPubMed
Seersholm, N, Wencker, M, Banik, N, et al. Does alpha-1 antitrypsin augmentation therapy slow the annual decline in FEV1 in patients with severe hereditary alpha-1 antitrypsin deficiency?Eur Respir J 1997;10:2260–63.CrossRefGoogle Scholar
Piitulainen, E, Eriksson, S. Decline in FEV1 related to smoking status in individuals with severe alpha-1 antitrypsin deficiency (PiZZ). Eur Respir J 1999;13:247–51.CrossRefGoogle Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×